Kathy Whitney

Heart Institute studying absorbable coronary stent

Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease.

Framingham Heart Study’s landmark impact examined

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease.

Researchers identify novel biomarker for diabetes risk

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.

Embolism not about to change young singer’s tune

As a member of the Tune Town Show Chorus, 20-year-old Kyla Hallums was used to belting out songs and thought it strange when she became short of breath on Sept. 1.

Heart Institute hits ventricular assist device milestone

Cardiac surgeons recently performed Vanderbilt Heart and Vascular Institute’s 100th ventricular assist device (VAD) implant.

‘Envelope’ reduces cardiac implant infections

Vanderbilt Heart and Vascular Institute is the first in the United States to use a new fully resorbable “envelope” that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.

1 19 20 21 22 23 25